Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05354882
Other study ID # 2021-A01570-41
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 29, 2022
Est. completion date December 2023

Study information

Verified date May 2023
Source Université Sorbonne Paris Nord
Contact Albane AA Aumaitre, PhD student
Phone 0033616883160
Email albane.au@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Benefits of physical activity (PA) as supportive care in cancer have been widely demonstrated by the scientific community. However, survivors who have completed chemo-radio-immunotherapy treatments doesn't achieve PA recommendations on average. This reinforces the need to identify factors influencing PA level, and to propose a multilevel model (macro-, meso-, micro-level) to understand better what facilitates the adoption and maintenance of active behaviour and what hinders it. To date, there is no ecological model in France explaining this behaviour in the post-treatment phase of breast, colorectal, prostate, and lung cancers. From this initial model, we seek to design an educational and motivational intervention in PA. Thus, the investigators propose to test the feasibility of implementing an individualized program to increase and maintain level of physical activity and to decrease sedentary behaviours in physically inactive cancer survivors. This program is based through and identification of barriers and facilitators of an active lifestyle among this population.


Description:

In 2008, 3 million French people had experienced cancer in the last 15 years, compared to 18 million in 2022. Post-treatment marks a break with the intensive care pathway. It frequently leads to changes in the lifestyle of these patients. During this period, behaviors conducive to maintaining their state of health remain important. Among these behaviors, Physical Activity (PA) is an integral part and brings many post-treatment benefits. Despite the evidence of PA benefits in adult cancer survivors who have completed chemo-radio-immunotherapy treatments, the majority of those with good prognosis cancer are insufficiently active. Patient survival tends to increase by 20% thanks to scientific progress and the improvement of cancer management. At the same time, patients experience adverse effects for an extended period after cancer treatment. It would take an average of 10 to 15 years to note a decrease in the psychological, physical, professional, and socio-economic repercussions of cancer. These repercussions do not totally disappear over time. We have a particular interest in this post-treatment period, where the end of treatments marks a break within the "clinical pathway". The patient then joins the "care pathway" where he/she needs to have an autonomous management of his/her health behaviour. The study of factors - clinical, psychological, cognitive, behavioural, social, or even linked to the clinical pathway and the geographical environment - involved in regular PA practice with breast, prostate, colorectal, or lung cancer survivors, would allow us an overview of what shapes a complex behaviour like PA. In view of these needs to better understand and act on the complex behaviour of active lifestyle, the main objective of our research is to design, implement, and evaluate an individualised educational and motivational program, constructed from an explanatory ecological model. The educational and motivational program thus conceived will help in supporting good prognosis and physically inactive cancer survivors (breast, colorectal, prostate, or lung cancers) in initiation and maintenance of their PA. Deployment of this interventional approach will provide more support to cancer survivors at the end of their treatment at a national level while considering the specificities of healthcare fields. To consider these variety, transferability criteria will be taken into account. Thus, the investigators propose to test the feasibility of implementing an individualized program to increase and maintain level of physical activity and to decrease sedentary behaviours in physically inactive cancer survivors. This program is based through and identification of barriers and facilitators of an active lifestyle among this population.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 2023
Est. primary completion date July 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - 18 years = age < 75 years - survivors of primary non-metastatic breast, lung, prostate or colorectal cancer (stage I, II or III and primary, second and relapse included) - 3 weeks to 20 years post-treatment (surgery, chemotherapy, radiation therapy and/or immunotherapy) not including hormonal therapy - Whose ability to participate in the APA intervention has been certified by a medical certificate issued by physician - Availability and willingness to invest in the DEFACTO study during the program (3 months) and during the post-program follow-up (12 months) - Participating, on average, in no more than 150 minutes of moderate physical activity or no more than 75 minutes of vigorous activity per week - Average at least 6 hours a day of sedentary behaviours - Able to read, understand and complete questionnaires in French - Able to use connected device (Vivosmart4®) and to perform simple operating actions (press a button, recharge the battery) - possessing a smartphone which can download Garmin Connect application ® - Able to walk unassisted - French speaking and living in France - having signed the consent form Exclusion Criteria: - Current evidence of metastatic disease - Having an absolute contraindication by a physician to practice PA - Using treatments that influence blood pressure, cardiotoxic drugs, painkillers (morphinics); - Using cane or walking aid - Deprived of liberty by judicial or administrative decision - Person under guardianship or curatorship - Pregnancy and/or lactating women - Being diagnosed of any cardiac abnormalities

Study Design


Intervention

Behavioral:
Physical activity program
The single group will access to the twelve-week DEFACTO program containing one adapted physical activity session, two discussion group sessions and several motivational interviewing

Locations

Country Name City State
France Laboratoire Educations et Promotion de la Santé UR3412 Bobigny

Sponsors (4)

Lead Sponsor Collaborator
Université Sorbonne Paris Nord Garmin International, Ligue contre le cancer, France, Stimulab

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other Weight in kilograms (weight and height will be combined to report BMI in kg/m^2) At Baseline (at inclusion)
Other Height in centimeters (height and weight will be combined to report BMI in kg/m^2) At Baseline (at inclusion)
Other Date of cancer diagnosis (month/year) At Baseline (at inclusion)
Other Tumor location and cancer recurrence or second primary cancer (breast, colorectal, lung or prostate) At Baseline (at inclusion)
Other Stage of cancer (I, /II, or /III) At Baseline (at inclusion)
Other Type of treatment (chemotherapy, radiation therapy, immunotherapy, hormonotherapy) At Baseline (at inclusion)
Other Clinical data Body Mass Index (BMI, kg/m^2), date of diagnosis (month/year), tumour location (breast, colorectal, lung or prostate), stage of cancer (I, /II, or /III), cancer recurrence or second primary cancer, type of treatment, date on the treatment end (chemotherapy, radiation therapy, immunotherapy, hormonotherapy + month/year); (close-ended questions) At Baseline (at inclusion)
Other Date on the treatment end (month/year) At Baseline (at inclusion)
Other Socio-demographic variables Educational qualifications, economic class-status, current professional situation, household type, habitat type, geographical environment (rural or /urban); (close-ended questions) At Baseline (at inclusion)
Primary Change of physical activity (connected device) Average daily steps, distance traveled, floors climbed, heart rate, cumulative duration of activities of moderate and vigorous intensities using VIVOSMART4® (Garmin) One week before initiation of DEFACTO intervention, during the intervention and intervention at Month 3 and Month 6 and Month 12
Secondary Change of physical activity by the Global Physical Activity Questionnaire (GPAQ) Change of physical activity evaluated by the GPAQ questionnaire, at baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention) At baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Secondary Assessment of life quality Assessment by using the Short-Form 12 questionnaire (SF-12) Life quality scores calculation At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Secondary Assessment of Health literacy level Assessment by using a single question concerning the need to resort refer to a health professional to understand health information At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Secondary Assessment of Knowledge about PA and its link with cancer Assessment by using specific questions of the Cancer Exercise Stereotypes Scale At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Secondary Physical activity barriers Assessment by using the "General determinants of PA" questionnaire. This tool examines 7 areas: 1) Lack of time; 2) Social influences; 3) Lack of energy; 4) Lack of willingness; 5) Fear of hurting yourself; 6) Lack of skill sets; 7) Lack of resources At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Secondary Transtheorical model's variables related to physical activity Assessment by using the "Stages of change" questionnaire, "Processes of change (POC)" questionnaire, "decisional balance" questionnaire, and "self-efficacy" questionnaire. At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
Secondary Motivation to physical activity pratice Types of motivation based on self-determination theory, assessment by using the Motivation Scale for by Physical Activity for Health Purposes At Baseline (at inclusion), and at the completion of intervention (12 weekends after the start of the intervention)
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A